Directory
>
Heather Schwoebel
Heather Schwoebel
Harvard Business Review Advisory Council Member | Alloy Therapeutics, Inc.
Boston, Massachusetts, United States
Heather Schwoebel
Summary
Heather Schwoebel is an accomplished Chief Business Officer at Alloy Therapeutics, where she drives innovation in biotechnology. With over 20 years of experience in biotech company formation, operations, and business development, she has a proven track record of building strategic collaborations and partnerships. Heather is dedicated to reducing barriers in drug development, ensuring that innovative medicines reach patients faster. Her leadership has secured collaborations with over 170 organizations, showcasing her ability to navigate complex negotiations. Prior to Alloy, she held significant roles at Verseau Therapeutics and Harbour Antibodies, contributing to her extensive knowledge in the life sciences sector. Heather is passionate about increasing representation in the industry and balances her professional life with personal interests like gardening and family time.
Heather Schwoebel
Work Experience
Harvard Business Review Advisory Council Member at
Harvard Business Review
August 2024 - Present
Chief Business Officer of Antibody Therapeutics and Head of Strategic Collaborations at
Alloy Therapeutics, Inc.
November 2021 - Present
Chief Operating Officer and Head of BD at
Alloy Therapeutics, Inc.
July 2021 - November 2021
Senior Vice President of BD at
Alloy Therapeutics, Inc.
October 2020 - July 2021
Vice President, Business Development at
Alloy Therapeutics, Inc.
January 2019 - September 2020
Director, Operations and Alliance Management at
Alloy Therapeutics
September 2018 - December 2018
Associate Director, Business Operations and Strategic Alliances at
Verseau Therapeutics
April 2017 - September 2018
Associate Director, External Alliances at
Harbour Antibodies
June 2013 - April 2017
Life Science Investment Team Support at
Atlas Venture
May 2002 - May 2013
Heather Schwoebel
Education
January 1993 - January 1995
American University, Undergraduate Studies
January 1990 - January 1993
Frequently Asked Questions about Heather Schwoebel
What is Heather Schwoebel email address?
Heather Schwoebel's primary email address is *****************@alloytx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Heather Schwoebel work for?
Heather Schwoebel is a Harvard Business Review Advisory Council Member at Alloy Therapeutics, Inc., a company specializing in Commercial physical research.
Where Heather Schwoebel graduated from?
Heather Schwoebel holds a degree in Hospitality Administration from Boston University.
How can I directly contact Heather Schwoebel?
To contact Heather Schwoebel directly, you can use the email address *****************@alloytx.com. Complete contact information is available upon registration with Muraena.
Who is Heather Schwoebel?
Heather Schwoebel is an accomplished Chief Business Officer at Alloy Therapeutics, where she drives innovation in biotechnology. With over 20 years of experience in biotech company formation, operations, and business development, she has a proven track record of building strategic collaborations and partnerships. Heather is dedicated to reducing barriers in drug development, ensuring that innovative medicines reach patients faster. Her leadership has secured collaborations with over 170 organizations, showcasing her ability to navigate complex negotiations. Prior to Alloy, she held significant roles at Verseau Therapeutics and Harbour Antibodies, contributing to her extensive knowledge in the life sciences sector. Heather is passionate about increasing representation in the industry and balances her professional life with personal interests like gardening and family time.
Heather`s contact details
*****************@alloytx.com
**********@atlasventure.com
Colleagues
General Partner
CTO, TCR Discovery and Engineering at Alloy Therapeutics | Founder and CEO at Keyway TCR Discovery
Vice President of Daedamab Business Development
Senior Vice President Therapeutic Discovery Strategies
VP Head of Protein Science & Bioanalytics